tiprankstipranks
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded Fund
Advertisement

IN:PHARMABEES ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Strong Buy
16Bullish
5Neutral
1Bearish
Oscillators
Buy
4Bullish
5Neutral
1Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Moving Averages Convergence Divergence (MACD) indicator is 0.36, suggesting Nippon India Nifty Pharma ETF Units Exchange Traded Fund is a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 20-Day exponential moving average is 26.95, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-Day exponential moving average is 26.22, making it a Buy.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Pivot Points

Aug 12, 2026, 10:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
26.14
26.66
26.96
27.48
27.78
28.30
28.60
Fibonacci
26.66
26.97
27.16
27.48
27.79
27.98
28.30

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Moving Averages

Aug 12, 2026, 10:49 PM
Period
Simple
Exponential
MA5
27.33Buy
27.32Buy
MA10
27.27Buy
27.20Buy
MA20
26.93Buy
26.95Buy
MA50
26.08Buy
26.22Buy
MA100
24.95Buy
25.37Buy
MA200
24.03Buy
24.11Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 10-Day exponential moving average is 27.20, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-Day exponential moving average is 25.37, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-day simple moving average is 26.08, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-day simple moving average is 24.95, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 200-day simple moving average is 24.03, creating a Buy signal.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Technical Analysis

Aug 12, 2026, 10:49 PM
Name
Value
Action
RSI (14)
68.39
Neutral
STOCH (9,6)
53.90
Neutral
STOCHRSI (14)
65.43
Neutral
MACD (12,26)
0.36
Buy
ADX (14)
20.22
Neutral
Williams %R
-29.63
Buy
CCI (14)
114.54
Sell
ATR (14)
0.70
-
Ultimate Oscillator
41.77
Neutral
ROC
3.55
Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Relative Strength Index (RSI) is 68.39, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Trend Strength Indicator (ADX) is 20.22, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Commodity Channel Index (CCI) is 114.54, creating a Sell signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Price Rate of Change (ROC) is 3.55, creating a Buy signal.

FAQ

Is PHARMABEES a Buy, Hold, or Sell?
Based on PHARMABEES’s technical indicators, PHARMABEES is a Strong Buy.
    What is PHARMABEES’s RSI (14)?
    PHARMABEES’s RSI (14) is 68.39, which suggests PHARMABEES is a Neutral.
      What is PHARMABEES’s MACD?
      PHARMABEES’s MACD is 0.36, which suggests PHARMABEES is a Buy.
        What is PHARMABEES’s 5-day moving average?
        PHARMABEES’s 5-day moving average is 27.33, which suggests PHARMABEES is a Buy.
          What is PHARMABEES’s 20-day moving average?
          PHARMABEES 20-day moving average is 26.93, which suggests PHARMABEES is a Buy.
            What is PHARMABEES’s 50-day moving average?
            PHARMABEES’s 50-day moving average is 26.08, which suggests PHARMABEES is a Buy.
              What is PHARMABEES’s 200-day moving average?
              PHARMABEES’s 200-day moving average is 24.03, which suggests PHARMABEES is a Buy.
                What is PHARMABEES’s Williams % R (14)?
                PHARMABEES’s Williams % R (14) is -29.63, which suggests PHARMABEES is a Buy.
                  What is PHARMABEES’s CCI (14)?
                  PHARMABEES’s CCI (14) is 114.54, which suggests PHARMABEES is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement